Press Releases
Please, enter cell line, author or any other phrase or word you would like to search for.
Gladstone Institutes, University of California and PHI form joint Center of Excellence
Gladstone Institutes, University of California in San Francisco and PHI recently formed San Francisco’s Center of Excellence for Holographic Imaging Cytometry.
New SelectScience eBook helps scientists choose the best cell imaging technology
A new cell imaging technology guide has been launched by leading independent science publisher SelectScience® to help scientists find the best equipment for their applications.
US National Institutes of Health intends to purchase HoloMonitor
The US National Institute of Aging intends to purchase a HoloMonitor instrument from Phase Holographic Imaging. The National Institute of Aging is part of the National Institutes of Health (NIH), a government agency to promote medical research.
Minor insider divestment
PHI Board member Jan Richardsson recently divested 5 328 shares in the company. “The reason for the sale is that I needed to balance an option loss linked to a previous employment”, comments Richardsson.
Correction regarding the publication date of coming interim report
PHI receives 18 MSEK through share options
On June 13, 2019, the exercise period of the TO 2 share options in Phase Holographic Imaging (“PHI”) ended. 632 520 (97.6 %) of the 648 338 outstanding options were exercised. PHI will thus receive approx. 17.8 MSEK before issuing expenses, which are expected to amount to approx. 0.8 MSEK.
PHI and leading supplier of cell analysis instrumentation sign agreement
Phase Holographic Imaging (PHI) and a major publicly traded international supplier of laboratory equipment and cell analysis instrumentation have entered an agreement aiming to determine the scope and nature of a future partnership. The agreement is a result of discussions between the company management teams, over an extended period time.
Investerarträff 28 maj 2019
Phase Holographic Imaging, inbjuder till investerarträff för befintliga aktieägare och övriga intresserade tisdagen den 28 maj 2019 klockan 16:30 i bolagets lokaler, Scheelevägen 22 i Lund.
PHI establish US subsidiary to foster US partnerships
As part of the ongoing expansion of activities on the US market, the Board of Directors of Phase Holographic Imaging (PHI) has initiated the process of establishing a fully owned subsidiary in the US.
PHI releases App Suite 2 – more apps and greater applicability
App Suite 2 is the second release in a series of planned App Suite releases, developed to provide automated live-cell studies to researchers worldwide in an unprecedented user-friendly workflow, using PHI’s HoloMonitor-technology.